Free Trial

Petrus Trust Company LTA Has $465,000 Stock Position in Maximus, Inc. $MMS

Maximus logo with Business Services background

Petrus Trust Company LTA reduced its position in Maximus, Inc. (NYSE:MMS - Free Report) by 36.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,819 shares of the health services provider's stock after selling 3,863 shares during the period. Petrus Trust Company LTA's holdings in Maximus were worth $465,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd increased its position in Maximus by 17,533.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock worth $36,000 after purchasing an additional 526 shares during the last quarter. UMB Bank n.a. increased its position in Maximus by 70.2% in the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after purchasing an additional 250 shares during the last quarter. GAMMA Investing LLC increased its position in Maximus by 67.1% in the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after purchasing an additional 294 shares during the last quarter. NBC Securities Inc. increased its position in Maximus by 114,900.0% in the 1st quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock worth $78,000 after purchasing an additional 1,149 shares during the last quarter. Finally, Blue Trust Inc. increased its position in Maximus by 32.8% in the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after purchasing an additional 303 shares during the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Stock Performance

NYSE:MMS traded down $0.55 during mid-day trading on Friday, hitting $89.54. 559,316 shares of the company's stock traded hands, compared to its average volume of 545,338. The firm has a 50 day moving average of $79.89 and a two-hundred day moving average of $73.15. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.94. The firm has a market capitalization of $5.05 billion, a price-to-earnings ratio of 16.49 and a beta of 0.61. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91.

Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.77. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter in the prior year, the company earned $1.74 EPS. The firm's revenue for the quarter was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, equities analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Sunday, August 31st. Investors of record on Friday, August 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.3%. Maximus's dividend payout ratio is presently 22.10%.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Maximus from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Strong Buy" and a consensus target price of $90.00.

Read Our Latest Stock Analysis on Maximus

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Read More

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.